SBMC proudly welcomes a new member to its growing ecosystem: Medjeduse, a visionary biotech startup on a mission to restore movement and sensation after traumatic accidents. Their bold promise? To cure traumatic nervous system injuries using cutting-edge biomaterials.
The connection between SBMC and Medjeduse began earlier this year, when Jean-Yves Nothias, CEO of Medjeduse, participated in the Biomaterials Hackathon — a two-day sprint where scientists, clinicians and entrepreneurs tackled real-world challenges in regenerative medicine.
“The hackathon was a moment of real alignment while having the opportunity to visit SBMC and the Eindhoven ecosystem,” says Jean-Yves Nothias. “I met passionate people who believe, like we do, that biomaterials can completely disrupt regenerative medicine including the nervous system. Joining SBMC felt like a natural next step as it could provide Medjeduse with the right capabilities and facilities for our biomaterial production needs.”
With a strong scientific foundation and a sharp focus on the nervous system, Medjeduse is developing implantable biomaterials designed to promote nerve regeneration and restore lost function after trauma — offering new hope to patients with spinal cord injuries.
“We’re excited to support Medjeduse in their journey,” adds Jan Rietsema, CEO of SBMC. “Their mission is ambitious, their science is strong, and their energy is infectious. It’s exactly the kind of company we want in our consortium.”
Moving from Concept to Clinic
By joining SBMC, Medjeduse gains access to world-class GMP facilities, expert guidance on clinical translation, and a dynamic community of like-minded innovators. The partnership also strengthens SBMC’s ambition to become Europe’s go-to platform for scaling biomaterial-based therapies.
Jean-Yves Nothias: “Our goal is to move fast, validate our materials in the right environment, and bring our therapy to the patients who need it most.”
With Medjeduse on board, SBMC adds a powerful voice to its consortium — and takes one step closer to a future where movement and sensation can be restored after traumatic paralysis.
